“`html
Healthcare costs continue to rise in France, prompting concern from the Assurance Maladie (French National Health Insurance). While the number of prescription drugs reimbursed has remained relatively stable, the overall financial burden on the healthcare system is increasing. From July 2024 to June 2025, 2.54 billion boxes of medication were reimbursed, a figure consistent with the past five years. However, net healthcare expenditure on pharmaceuticals increased substantially.
Rising Pharmaceutical Costs in France
In 2024, net pharmaceutical expenditure reached €27.2 billion, a 7.2% increase year-on-year. According to the Assurance Maladie, this rise isn’t solely attributable to demographic shifts and the prevalence of chronic diseases. A